We are live on ! Find out more
OM icon

Outset Medical

140 hedge funds and large institutions have $308M invested in Outset Medical in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.36% more ownership

Funds ownership: 7.2%7.55% (+0.36%)

8% less funds holding

Funds holding: 152140 (-12)

16% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 43

24% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 49

47% less capital invested

Capital invested by funds: $584M → $308M (-$276M)

91% less call options, than puts

Call options by funds: $273K | Put options by funds: $3.16M

Holders
140
Holders Change
-12
Holders Change %
-7.89%
% of All Funds
2.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
36
Reduced
43
Closed
49
Calls
$273K
Puts
$3.16M
Net Calls
-$2.89M
Net Calls Change
-$3.02M

OM Hedge Fund Activity: Q4 2023 in Review

140 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2023, worth a combined $308M — down 47% from $584M a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of OM and 37 opened new positions — a net loss of 12 holders — while 43 trimmed existing stakes and 36 added.

The largest buyer was Morgan Stanley, adding an estimated $33.3M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $21M sold.

  • 140 institutional investors held Outset Medical (OM) as of Q4 2023, down from 152 in Q3 2023.
  • Funds reported $308M of Outset Medical stock for Q4 2023, down 47% quarter-over-quarter.
  • 37 funds opened new Outset Medical positions in Q4 2023 and 49 closed out, a net change of -12 holders.
  • The largest Outset Medical buyer in Q4 2023 was Morgan Stanley, an estimated $33.3M added.
  • The largest Outset Medical seller in Q4 2023 was Champlain Investment Partners, an estimated $21M sold.

Based on aggregated 13F filings for Q4 2023.